You just read:

Capricor Therapeutics Announces Positive Six-Month Results from the Randomized Phase I/II HOPE Clinical Trial in Duchenne Muscular Dystrophy

News provided by

Capricor Therapeutics, Inc.

Apr 25, 2017, 06:00 ET